BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0960
+0.0020 (2.13%)
Mar 18, 2026, 4:10 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 35.39 million as of March 18, 2026. Its market cap has decreased by -7.89% in one year.
Market Cap
35.39M
Enterprise Value
35.50M
Revenue
2.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 35.39M, a decrease of -31.57%. That is a compound annual growth rate of -7.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 34.66M | -10.33% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 867.57M |
| Healius | 428.42M |
| Australian Clinical Labs | 381.75M |
| Monash IVF Group | 249.37M |
| Rhythm Biosciences | 68.92M |
| Cryosite | 58.33M |
| Microba Life Sciences | 48.72M |
| INOVIQ | 47.16M |